Characteristics of abnormal menstrual cycle and polycystic ovary syndrome in community and hospital populations

Chinese Medical Journal

Volumn 123, Issue 16, 2010, Pages 2185-2189

  Ma, Yan Min ^a,b   Li, Rong ^a   Qiao, Jie ^a   Zhang, Xiao Wei ^a   Wang, Shu Yu ^b   Zhang, Qiu Fang ^a   Li, Li ^a   Tu, Bin Bin ^a   Zhang, Xue ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Community; Hospital; Menstrual cycle; Polycystic ovary syndrome

Indexed keywords

ADULT; AGE; AMENORRHEA; ARTICLE; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOMETRIUM HYPERPLASIA; FAMILY HISTORY; FEMALE; HUMAN; HYPERANDROGENISM; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; MENSTRUATION DISORDER; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ADULT; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME;

EID: 77956098405     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.16.005     Document Type: Article

References (20)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082.
2. Rudnicka, E., W. Wierzba, and S. Radowicki. Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome. Ginekol Pol 2009; 80: 103-106.
3. Chittenden BG, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009; 19: 398-405.
4. Sharma ST, Nestler JE. Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers. Best Pract Res Clin Endocrinol Metab 2006; 20: 245-260.
5. Iatrakis G, Tsionis C, Adonakis G, Stoikidou M, Anthouli-Anagnostopoulou F Parava M. Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium. Eur J Obstet Gynecol Reprod Biol 2006; 127: 218-221.
6. Shen ZQ, Zhu HT, Lin JF. Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives. Obstet Gynecol 2008; 112(2 Pt 2): 465-467.
7. Strowitzki T, Capp E, von Eye Corleta H. The degree of cycle irregularity correlates with the grade of endocrine and metabolic disorders in PCOS patients. Eur J Obstet Gynecol Reprod Biol 2010; 149: 178-181.
8. Hahn S, Tan S, Elsenbruch S, Quadbeck B, Herrmann BL, Mann K. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res 2005; 37: 438-444.
9. Dewailly D. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488.
10. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003; 9: 505-514.
11. March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010; 25: 544-551.
12. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19: 41-47.
13. Norman RJD, Legro D, Hickey RS. Polycystic ovary syndrome. Lancet 2007; 370: 685-697.
14. Kumarapeli V, Seneviratne Rde, Wijeyaratne A, Yapa CN, Dodampahala RM. A simple screening approach for assessing community prevalence and phenotype of polycystic ovary syndrome in a semi-urban population in Sri Lanka. Am J Epidemiol 2008; 168: 321-318.
15. Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol 2008; 139: 59-64.
16. Agarwal A, Venkat A. Questionnaire study on menstrual disorders in adolescent girls in Singapore. J Pediatr Adolesc Gynecol 2009; 22: 365-371.
17. Pillay OC, Te Fong LF, Crow JC, Benjamin E, Mould T. The association between polycystic ovaries and endometrial cancer. Hum Reprod 2006; 21: 924-929.
18. Azziz R. Diagnostic criteria for polycystic ovary syndrome: a reappraisal. Fertil Steril 2005; 83: 1343-1346.
19. Azziz R. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 2006; 91: 781-785.
20. Hassa H, Tanir HM, Yildiz Z. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism. Arch Gynecol Obstet 2006; 274: 227-232.